Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2005
10/13/2005WO2005095401A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005WO2005095400A1 Azaindoles useful as inhibitors of jak and other protein kinases
10/13/2005WO2005095399A2 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
10/13/2005WO2005095398A1 Substituted 1,4,8-triazaspiro[4.5]decan-2-one compounds
10/13/2005WO2005095397A1 Tetrahydropyridoindole derivatives
10/13/2005WO2005095396A1 8-phenoxy-ϝ carboline derivatives
10/13/2005WO2005095395A2 Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094828A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005WO2005094531A2 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228013 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228004 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses
10/13/2005US20050228002 Anti proliferavtive agents; small molecule inhibitors of KSP(kinesin-related proteins); N-(3-aminopropyl)-N-[1-(3-benzyl-4-oxo-6,7,8 ,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-2-yl)propyl]-4-bromobenzamide
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227977 Substituted 1,2,5,10-tetrahydropyridazino [4,5-b]quinoline-1,10-dione compounds and methods for the treatment of pain
10/13/2005US20050227958 Polycyclic pyridines as potassium ion channel modulators
10/13/2005US20050227156 Electrophotographic photoreceptor containing naphthalenetetracarboxylic acid diimide derivatives and electrophotographic imaging apparatus employing the same
10/13/2005US20050227076 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
10/13/2005DE102004010194A1 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln 4-benzimidazole-2-yl-pyridazin-3-one derivatives, their preparation and use in medicaments
10/13/2005CA2564018A1 8-phenoxy-.gamma. carboline derivatives
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2560684A1 Substituted 1,4,8-triazaspiro[4.5]decan-2-one compounds
10/13/2005CA2560454A1 Azaindoles useful as inhibitors of jak and other protein kinases
10/13/2005CA2559863A1 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
10/13/2005CA2558923A1 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/13/2005CA2558019A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005CA2554551A1 Compositions useful as inhibitors of protein kinases
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583531A1 Heteroaryl- substituted pyrrolo' 2, 3- b! pyridine derivatives as crf receptor antagonists
10/12/2005EP1414819B1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005CN1681816A Novel pyrazolopyridines as cyclin dependent kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681814A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via 1H-imidazo [4, 5-C] quinolin-4-phthalimide intermediates
10/12/2005CN1681813A Synthesis of indolizines
10/12/2005CN1681810A Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1680879A Electrophotographic photoreceptor containing naphthalenetetracarboxylic acid diimide derivatives and electrophotographic imaging apparatus employing the same
10/12/2005CN1680375A Bisphenols monomer with imide structure and its synthesis
10/12/2005CN1680374A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680365A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1679586A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222525C Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953855 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953790 CGRP receptor antagonists
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092895A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005WO2005092894A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092858A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092335A1 TETRAHYDRO-β-CARBOLINE COMPOUNDS AND USE THEREOF
10/06/2005WO2005092066A2 Imidazole compounds
10/06/2005WO2005069894A3 Conformationally constrained smac mimetics and the uses thereof
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222416 1,6,9,14-teltrasubstituted terrylene tetracarboxylic diimides
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222210 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222198 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
10/06/2005US20050222197 Novel pyrazolopyridine derivatives as pharmaceutical agents
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222192 Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
10/06/2005US20050222177 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
10/06/2005US20050222170 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
10/06/2005US20050222168 Beta-carboline derived guanidine alkaloids, tiruchenduramine
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222148 Phenylaminopropanol derivatives and methods of their use
1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 646